Touch Neurology

Extended-release Antiepilepsy Drugs

Extended-release Antiepilepsy Drugs

Extended-release Antiepilepsy Drugs— Review of the Effects of Once-daily Dosing on Tolerability, ...

Basim M Uthman

US Neurology, 2014;10(1):30–7

Pseudobulbar Affect Alzheimer’s & Dementia

Pseudobulbar Affect Alzheimer’s & Dementia

Identifying Pseudobulbar Affect in Alzheimer’s Disease and Dementia

David W Crumpacker, William A Engelman

US Neurology, 2014;10(1):10–4

Genetic Risk Factors - Restless Legs Syndrome

Genetic Risk Factors - Restless Legs Syndrome

Latest Perspectives in Genetic Risk Factors for Restless Legs Syndrome

Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, José AG Agúndez

European Neurological Review, 2013;8(2):90–6

Ischaemic Lacunar Stroke

Ischaemic Lacunar Stroke

Cognitive Impairment in Ischaemic Lacunar Stroke

Adrià Arboix, Lorena Blanco-Rojas

European Neurological Review, 2013;8(2):144–8

Latest Videos

Alzheimer's Society looks at the science behind the stories that coconut oil can be used to treat Alzheimer's disease.
Researchers at King's College London and Oxford University say that, in trials, they can identify the Alzheimer`s disease in 87 percent of cases.
Stephanie Schultz, B.Sc., of the Wisconsin Alzheimer's Disease Research Center discusses new research suggesting that participation in mentally stimulating activities.
Sean Pittock, M.D., discusses what providers should know about autoimmune dementia, the testing approach, as well as interpretation, follow-up and additional considerations once the test has been orde
Dr. Andrew Duker of the UC Gardner Center discuss the benefits and risks of DBS surgery and the careful process of determining whether DBS can improve symptoms and quality of life.
Professor John Duncan, Medical Director of the UK Epilepsy Society, discusses how epilepsy symptoms can be minimized with greater awareness of the condition among patients and physicians.
Customize This